Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation

Transplant Infectious Disease

Volumn 14, Issue 2, 2012, Pages 198-205

  Bergamasco, M D ^a   Barroso Barbosa, M ^a   de Oliveira Garcia, D ^b   Cipullo, R ^a   Moreira, J C M ^a   Baia, C ^a   Barbosa, V ^a   Abboud, C S ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Carbapenem resistance; Carbapenemase; Infection; Klebsiella pneumoniae; KPC, solid organ transplantation

Indexed keywords

AMIKACIN; CARBAPENEM; CARBAPENEMASE; CREATININE; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; KLEBSIELLA PNEUMONIAE CARBAPENEMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; BRAZIL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE INFECTION; LIVER TRANSPLANTATION; MALE; NEUROTOXICITY; ORGAN TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN DISCOLORATION; SOLID ORGAN TRANSPLANTATION; SURGICAL INFECTION; URINARY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES;

EID: 84859873385     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00688.x     Document Type: Article

References (22)

1. Linares L, García-Goez JF, Cervera C, et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009; 41 (6): 2262-2264.
2. Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM. Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant 2009; 9 (4): 835-843.
3. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transplant 2004; 10 (7): 844-849.
4. Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 2009; 122 (9): 866-873.
5. Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010; 50 (3): 364-373.
6. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009; 53 (1): 333-334.
7. Lopez JA, Correa A, Navon-Venezia S, et al. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect 2011; 17 (1): 52-56.
8. Mathers AJ, Cox HL, Bonatti H, et al. Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis 2009; 11 (3): 257-265.
9. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29 (12): 1099-1106.
10. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36 (5): 309-332.
11. Abboud CS, Bergamasco MD, Doi AM, et al. First report of investigation into an outbreak due to carbapenemase-producing Klebsiella pneumoniae in a tertiary Brazilian hospital, with extension to a patient in the community. Journal of Infection Prevention Jul 2011; 12 (4): 150-153.
12. Clinical and Laboratory Standards Institute. 2009A. Performance Standards for Antimicrobial Susceptibility Testing, 19th Informational Supplement CLSI Document M100-S19. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2009.
13. Racheed JK, Biddle JW, Anderson KF, et al. Detection of Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolysing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol 2008; 46 (6): 2066-2069.
14. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33 (9): 2233-2239.
15. Mouloudi E, Protonotariou E, Zagorianou A, et al. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 2010; 31 (12): 1250-1256.
16. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9 (4): 228-236.
17. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010; 65 (6): 1119-1125.
18. Castanheira M, Sader HS, Deshpande LM, et al. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2008; 52 (2): 570-573.
19. Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin Microbiol Infect 2011; 17 (8): 1135-1141.
20. Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007; 60 (6): 1206-1215.
21. Elemam A, Rahimian J, Doymaz M. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae. J Clin Microbiol 2010; 48 (10): 3558-3562.
22. Lee J, Patel G, Huprikar S, Calfee DP, Jenkins SG. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection. J Clin Microbiol 2009; 47 (5): 1611-1612.